Yichu Yuan
No.88 Jiefang Road
Hangzhou, 310009, China
Hangzhou, 310009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
The efficacy and safety of disitamab vedotin combined with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: a multicenter real-world study.
Journal: Cancer immunology, immunotherapy : CII
Published: March 27, 2025
A rare Ewing-like small round cell tumor in prostate: a case report and literature review.
Journal: Journal of cancer research and clinical oncology
Published: November 08, 2023
Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world study.
Journal: Cancer medicine
Published: November 14, 2022
The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemcitabine chemotherapy.
Journal: Oncoimmunology
Published: September 23, 2022
Primary squamous cell carcinoma of renal parenchyma: A case report and literature review.
Journal: Frontiers in oncology
Published: September 05, 2022
Prospective Clinical Trial of the Oncologic Outcomes and Safety of Extraperitoneal Laparoscopic Extended Retroperitoneal Lymph Node Dissection at Time of Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Journal: Frontiers in oncology
Published: October 08, 2021
Characterization of Molecular Heterogeneity Associated With Tumor Microenvironment in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy.
Journal: Frontiers in cell and developmental biology
Published: July 05, 2021
Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma.
Journal: European urology
Published: July 03, 2021
Influence of American Society of Anesthesiologists Score on Oncologic Outcomes in Patients With Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Large-Sample Study in Two Institutions.
Journal: Frontiers in oncology
Published: June 11, 2021
Clinical outcomes of second-line treatment following first-line VEGFR-TKI failure in patients with metastatic renal cell carcinoma: a comparison of axitinib alone and axitinib plus anti-PD-1 antibody.
Journal: Cancer communications (London, England)
Published: March 14, 2021
Characterization of the intestinal absorption of morroniside from Cornus officinalis Sieb. et Zucc via a Caco-2 cell monolayer model.
Journal: PloS one
Published: December 24, 2019
Last Updated: 09/26/2026